PI4K

特异性亚型抑制剂

• PI4KIIIα
• PI4KIIIβ Selective

PI4K产品

目录号	产品描述	文献引用	实验数据
S1489	PIK-93 PIK-93是第一个有效的，人工合成的PI4K(PI4KIIIβ)抑制剂，IC50为19 nM；抑制PI3Kα，IC50为39 nM。	J Immunol, 2021, 206(9):2061-2074 Sci Rep, 2021, 11(1):2290 Sci Rep, 2021, 11(1):2290	After starved in serum-free medium for 24h,A549 cells incubated with the indicated concentrations of PIK-93 for 3h,followed by 20-minute stimolation of 100ng/ml EGF.
S2728	AG-1478 (Tyrphostin AG-1478) AG-1478 (Tyrphostin AG-1478, NSC 693255) 是一种选择性EGFR抑制剂，在无细胞试验中IC50为3 nM，对HER2-Neu，PDGFR，Trk，Bcr-Abl和InsR几乎没有作用活性。AG-1478（Tyrphostin AG-1478）通过靶向 phosphatidylinositol 4-kinase IIIα (PI4KA) 抑制脑心肌炎病毒encephalomyocarditis virus (EMCV)和丙型肝炎病毒hepatitis c virus (HCV)。	J Am Chem Soc, 2021, 10.1021/jacs.1c05386 Theranostics, 2021, 11(3):996-1015 Oncogenesis, 2021, 10(3):25	A549 cells were treated with G15 (a specific antagonist of GPR30, 1 uM), AG1478 (a potent antagonist of EGFR, 10 uM), BPA (10-5 M) alone for 15 min or BPA after a 90-min pretreatment with G15 or AG1478 for 15 min. Then the expression of p-ERK1/2 and total ERK1/2 were measured by western blot analysis.
S0041	UCB9608 UCB9608 (compound 44) 是一种有效的、选择性的 PI4KIIIβ 的口服生物利用的抑制剂，其IC50值为 11 nM。UCB9608 是一种有效的免疫抑制剂，可改善代谢稳定性并表现出出色的药代动力学特性。
S6571	BQR695 BQR695 (NVP-BQR695)是PI4KIIIβ抑制剂，对人源PI4KIIIβ的IC50值约为90 nM。
S6574	KDU691 KDU691是疟原虫PI4K特异性抑制剂，对其休眠子形式和肝内裂殖体的IC50值分别为0.18 μM和0.061 μM。

目录号	产品描述	文献引用	实验数据
S1489	PIK-93 PIK-93是第一个有效的，人工合成的PI4K(PI4KIIIβ)抑制剂，IC50为19 nM；抑制PI3Kα，IC50为39 nM。	J Immunol,2021, 206(9):2061-2074 Sci Rep,2021, 11(1):2290 Sci Rep,2021, 11(1):2290	After starved in serum-free medium for 24h,A549 cells incubated with the indicated concentrations of PIK-93 for 3h,followed by 20-minute stimolation of 100ng/ml EGF.
S2728	AG-1478 (Tyrphostin AG-1478) AG-1478 (Tyrphostin AG-1478, NSC 693255) 是一种选择性EGFR抑制剂，在无细胞试验中IC50为3 nM，对HER2-Neu，PDGFR，Trk，Bcr-Abl和InsR几乎没有作用活性。AG-1478（Tyrphostin AG-1478）通过靶向 phosphatidylinositol 4-kinase IIIα (PI4KA) 抑制脑心肌炎病毒encephalomyocarditis virus (EMCV)和丙型肝炎病毒hepatitis c virus (HCV)。	J Am Chem Soc,2021, 10.1021/jacs.1c05386 Theranostics,2021, 11(3):996-1015 Oncogenesis,2021, 10(3):25	A549 cells were treated with G15 (a specific antagonist of GPR30, 1 uM), AG1478 (a potent antagonist of EGFR, 10 uM), BPA (10-5 M) alone for 15 min or BPA after a 90-min pretreatment with G15 or AG1478 for 15 min. Then the expression of p-ERK1/2 and total ERK1/2 were measured by western blot analysis.
S0041	UCB9608 UCB9608 (compound 44) 是一种有效的、选择性的 PI4KIIIβ 的口服生物利用的抑制剂，其IC50值为 11 nM。UCB9608 是一种有效的免疫抑制剂，可改善代谢稳定性并表现出出色的药代动力学特性。
S6571	BQR695 BQR695 (NVP-BQR695)是PI4KIIIβ抑制剂，对人源PI4KIIIβ的IC50值约为90 nM。
S6574	KDU691 KDU691是疟原虫PI4K特异性抑制剂，对其休眠子形式和肝内裂殖体的IC50值分别为0.18 μM和0.061 μM。